Tower Research Capital LLC (Trc) Idera Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.23 - $0.43 $1,549 - $2,896	6,736 Added 43.98%	22,052 $8,000
Q3 2022 Nov 10, 2022	SELL	$0.38 - $0.53 $4,753 - $6,629	-12,509 Reduced 44.96%	15,316 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.74 $7,929 - $18,337	24,780 Added 813.79%	27,825 $13,000
Q1 2022 May 12, 2022	SELL	$0.41 - $0.7 $780 - $1,332	-1,903 Reduced 38.46%	3,045 $2,000
Q4 2021 Feb 14, 2022	BUY	$0.53 - $1.03 $2,181 - $4,239	4,116 Added 494.71%	4,948 $3,000
Q3 2021 Nov 15, 2021	SELL	$1.0 - $1.18 $7,901 - $9,323	-7,901 Reduced 90.47%	832 $1,000
Q2 2021 Aug 16, 2021	BUY	$1.01 - $1.58 $669 - $1,047	663 Added 8.22%	8,733 $11,000
Q1 2021 May 17, 2021	BUY	$1.23 - $5.98 $1,766 - $8,587	1,436 Added 21.65%	8,070 $11,000
Q4 2020 Feb 16, 2021	BUY	$2.09 - $5.18 $11,028 - $27,334	5,277 Added 388.87%	6,634 $24,000
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.68 $831 - $1,302	486 Added 55.8%	1,357 $3,000
Q2 2020 Aug 13, 2020	BUY	$1.23 - $2.12 $768 - $1,325	625 Added 254.07%	871 $2,000
Q1 2020 May 15, 2020	SELL	$1.06 - $2.15 $18,062 - $36,636	-17,040 Reduced 98.58%	246 $0
Q4 2019 Feb 07, 2020	BUY	$1.45 - $2.79 $5,425 - $10,440	3,742 Added 27.63%	17,286 $32,000
Q3 2019 Nov 05, 2019	BUY	$2.12 - $3.31 $13,099 - $20,452	6,179 Added 83.9%	13,544 $39,000
Q2 2019 Aug 13, 2019	BUY	$2.37 - $3.97 $5,567 - $9,325	2,349 Added 46.83%	7,365 $19,000
Q1 2019 May 14, 2019	SELL	$2.33 - $3.79 $9,177 - $14,928	-3,939 Reduced 43.99%	5,016 $13,000
Q4 2018 Feb 14, 2019	BUY	$2.77 - $9.38 $21,824 - $73,905	7,879 Added 732.25%	8,955 $25,000
Q3 2018 Nov 13, 2018	BUY	$5.53 - $11.36 $5,950 - $12,223	1,076 New	1,076 $10,000

Others Institutions Holding IDRA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About IDERA PHARMACEUTICALS, INC.

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

More about IDRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account